To receive your instant certificate, you must "Sign In" or "Sign Up" in the top right corner.
ORIGINAL RELEASE: December 21, 2020
EXPIRATION: December 31, 2021
MAXIMUM CREDITS: 2.0 AMA PRA Category 1 Credits™
CLICK HERE TO PROCEED TO PROGRAM
ACTIVITY DESCRIPTION AND PURPOSE
Presbyopia is an age-related impairment in near vision that typically becomes functionally apparent to individuals at or after age 40. Presbyopia can adversely affect the quality of life of the estimated 110 million adults in the United States. Limitations and drawbacks associated with current options available to address presbyopia highlight the need for and interest in new options; topical pharmacologic therapies under investigation for the condition hold promise. This educational activity provides an overview of the age-related loss of accommodative amplitude underlying presbyopia and of emerging topical therapies for improving near-vision function of people with presbyopia. Perspectives on patient selection for the pharmacologic treatments under investigation and potential opportunities for practice growth stemming from this new therapeutic category are also discussed. The desired results of this educational activity are to keep eye care practitioners up to date on potential practice-changing advances in the treatment of presbyopia.
This continuing medical education activity is provided by MedEdicus LLC.
This continuing medical education activity is supported through an unrestricted educational grant from Allergan.
This CME activity is copyrighted to MedEdicus LLC ©2020. All rights reserved. 226 CLICK HERE TO PROCEED TO PROGRAM